We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 10, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. ETFs recently featured in the blog include: Breakwave Tanker Shipping ETF (BWET - Free Report) , Global X Gold Explorers ETF (GOEX - Free Report) , iShares MSCI Global Silver and Metals Miners ETF (SLVP - Free Report) , Global X Lithium & Battery Tech ETF (LIT - Free Report) and Virtus LifeSci Biotech Clinical Trials ETF (BBC - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Best-Performing ETFs of Last Week
Wall Street delivered a subdued performance last week. The S&P 500 advanced about 0.3%, the Dow Jones lost about 0.3% and the Nasdaq 100 gained 1%. The Alphabet-led tech rally and Fed rate cut hopes boosted the growth segment.
Below, we highlight a few key events of last week.
Inside the Tech Rally
Tech giants just had an epic week, adding $420 billion in market cap to reach a combined $21 trillion valuation (as quoted on CNBC) despite NVIDIA's dip. Alphabet surged about 11.6% last week. Apple gained 3.1% after a U.S. court handed Google a limited antitrust penalty, and allowed it to maintain its search deal with Apple (read: Alphabet's Stock Jumps as Antitrust Fears Ease: ETFs in Focus).
Although Alphabet was slapped with a $3.45 billion EU fine last week, investors paid more attention to the U.S. win. Meanwhile, Broadcom soared on a new $10 billion customer, while Tesla rose on Elon Musk's proposed pay package (per the abovementioned CNBC article). The gains cemented Big Tech's ruling position.
Downbeat Jobs Data
The U.S. economy added 22,000 jobs in August 2025, lower than an upwardly revised 79,000 in July and market forecasts of 75,000, as quoted on tradingeconomics. The data reinforced the softness in the labor market.
Jobs data for June were revised down by 27,000, and the change for July was revised up by 6,000. With these revisions, the previously reported employment data for June and July combined was reduced by 21,000. The unemployment rate at 4.3% changed little in August, per government data.
Job growth was mainly noticed in sectors such as health care (+31,000) and social assistance (+16,000). Job losses were pronounced in wholesale trade (12,000) and manufacturing (12,000).
Fed Rate Cut Bet Strengthens
The Fed will likely cut interest rates in September after Chair Jerome Powell hinted at a reduction in his highly anticipated Jackson Hole speech. There are 89% chances (at the time of writing) of a 25-bp rate cut in September, per the CME FedWatch Tool, while 11% chances shifted to the 50-bp rate cut. A softer labor market has probably led the market to this pricing pattern.
Winning ETFs in Focus
Against this backdrop, below we have highlighted a few winning exchange-traded funds (ETFs) of last week (data as per tradingview.com).
Breakwave Tanker Shipping ETF – Up 12.1%
The underlying Breakwave Tanker Futures Index follows the near-dated futures market on a constant rolling basis.The ETF offers long exposure to the crude oil tanker shipping market by investing in a portfolio of near-term futures contracts tied to indices that track the cost of transporting crude oil.
Global X Gold Explorers ETF – Up 12.1%
Gold prices have been steady lately, thanks to higher safe-haven demand. The Fed rate cut bets also favored the non-interest-paying metal ETFs. As mining stocks often act as leveraged plays of the underlying metal, gold mining ETFs surged last week.
iShares MSCI Global Silver and Metals Miners ETF – Up 10.5%
Silver prices have been hovering around $40 an ounce, marking the strongest level since 2011, per tradingeconomics. The silver market is expected to see a deficit for the fifth successive year in 2025, according to the Silver Institute. As a result, silver bullion ETF SLV gained 5.3% last week. Since mining stocks often surge more than the underlying metal, SLVP recorded a spurt in price last week.
Global X Lithium & Battery Tech ETF – Up 6.4%
There were reports in August that battery maker Contemporary Amperex Technology, CATL, suspended production at a mine in China that is instrumental in supplying to the global market, as quoted on CNBC. The mine produces about 4% of the global lithium supply forecast for 2025, according to Morgan Stanley, as quoted in the abovementioned CNBC article. As fears of a supply crunch rose, lithium ETF prices jumped.
Virtus LifeSci Biotech Clinical Trials ETF – Up 6.1%
Biotech companies often depend on equity and debt financing to raise funds. In a low-rate environment, the cost of capital falls, which is a beneficial scenario for biotech companies. With Fed rate cuts likely in September, biotech firms probably saw a surge.
Boost Your Portfolio with Our Top ETF Insights
Zacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox every week.
Don't miss out on this valuable resource. It's free!
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC
For Immediate Release
Chicago, IL – September 10, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. ETFs recently featured in the blog include: Breakwave Tanker Shipping ETF (BWET - Free Report) , Global X Gold Explorers ETF (GOEX - Free Report) , iShares MSCI Global Silver and Metals Miners ETF (SLVP - Free Report) , Global X Lithium & Battery Tech ETF (LIT - Free Report) and Virtus LifeSci Biotech Clinical Trials ETF (BBC - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Best-Performing ETFs of Last Week
Wall Street delivered a subdued performance last week. The S&P 500 advanced about 0.3%, the Dow Jones lost about 0.3% and the Nasdaq 100 gained 1%. The Alphabet-led tech rally and Fed rate cut hopes boosted the growth segment.
Below, we highlight a few key events of last week.
Inside the Tech Rally
Tech giants just had an epic week, adding $420 billion in market cap to reach a combined $21 trillion valuation (as quoted on CNBC) despite NVIDIA's dip. Alphabet surged about 11.6% last week. Apple gained 3.1% after a U.S. court handed Google a limited antitrust penalty, and allowed it to maintain its search deal with Apple (read: Alphabet's Stock Jumps as Antitrust Fears Ease: ETFs in Focus).
Although Alphabet was slapped with a $3.45 billion EU fine last week, investors paid more attention to the U.S. win. Meanwhile, Broadcom soared on a new $10 billion customer, while Tesla rose on Elon Musk's proposed pay package (per the abovementioned CNBC article). The gains cemented Big Tech's ruling position.
Downbeat Jobs Data
The U.S. economy added 22,000 jobs in August 2025, lower than an upwardly revised 79,000 in July and market forecasts of 75,000, as quoted on tradingeconomics. The data reinforced the softness in the labor market.
Jobs data for June were revised down by 27,000, and the change for July was revised up by 6,000. With these revisions, the previously reported employment data for June and July combined was reduced by 21,000. The unemployment rate at 4.3% changed little in August, per government data.
Job growth was mainly noticed in sectors such as health care (+31,000) and social assistance (+16,000). Job losses were pronounced in wholesale trade (12,000) and manufacturing (12,000).
Fed Rate Cut Bet Strengthens
The Fed will likely cut interest rates in September after Chair Jerome Powell hinted at a reduction in his highly anticipated Jackson Hole speech. There are 89% chances (at the time of writing) of a 25-bp rate cut in September, per the CME FedWatch Tool, while 11% chances shifted to the 50-bp rate cut. A softer labor market has probably led the market to this pricing pattern.
Winning ETFs in Focus
Against this backdrop, below we have highlighted a few winning exchange-traded funds (ETFs) of last week (data as per tradingview.com).
Breakwave Tanker Shipping ETF – Up 12.1%
The underlying Breakwave Tanker Futures Index follows the near-dated futures market on a constant rolling basis.The ETF offers long exposure to the crude oil tanker shipping market by investing in a portfolio of near-term futures contracts tied to indices that track the cost of transporting crude oil.
Global X Gold Explorers ETF – Up 12.1%
Gold prices have been steady lately, thanks to higher safe-haven demand. The Fed rate cut bets also favored the non-interest-paying metal ETFs. As mining stocks often act as leveraged plays of the underlying metal, gold mining ETFs surged last week.
iShares MSCI Global Silver and Metals Miners ETF – Up 10.5%
Silver prices have been hovering around $40 an ounce, marking the strongest level since 2011, per tradingeconomics. The silver market is expected to see a deficit for the fifth successive year in 2025, according to the Silver Institute. As a result, silver bullion ETF SLV gained 5.3% last week. Since mining stocks often surge more than the underlying metal, SLVP recorded a spurt in price last week.
Global X Lithium & Battery Tech ETF – Up 6.4%
There were reports in August that battery maker Contemporary Amperex Technology, CATL, suspended production at a mine in China that is instrumental in supplying to the global market, as quoted on CNBC. The mine produces about 4% of the global lithium supply forecast for 2025, according to Morgan Stanley, as quoted in the abovementioned CNBC article. As fears of a supply crunch rose, lithium ETF prices jumped.
Virtus LifeSci Biotech Clinical Trials ETF – Up 6.1%
Biotech companies often depend on equity and debt financing to raise funds. In a low-rate environment, the cost of capital falls, which is a beneficial scenario for biotech companies. With Fed rate cuts likely in September, biotech firms probably saw a surge.
Boost Your Portfolio with Our Top ETF Insights
Zacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox every week.
Don't miss out on this valuable resource. It's free!
Get it now >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.